ProBioGen and Thermo Fisher Scientific Gibco Freedom ExpiCHO-S Kit

Wednesday, 09 November, 2022 | Supplied by: Thermo Fisher Scientific


ProBioGen and Thermo Fisher Scientific have teamed up to develop the Gibco Freedom ExpiCHO-S Kit. The kit allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.

The kit uses Thermo Fisher’s ExpiCHO-S cell line and a powerful media platform specifically developed for it. The kit is based on a novel set of ProBioGen vectors equipped with strong promoters, selection markers and protective elements providing expression stability. Together with a simple workflow optimised by ProBioGen, the kit provides short development time, reproducibly high titres (3–5 g/L) and high expression stability.

Generating a stable and high-performing cell line is the starting point for successful pharmaceutical development. With this in mind, the kit allows a seamless transition from transient to stable production reproducing previously found product modifications. Moreover, the specific ProBioGen vector composition offers flexibility not only for antibodies but in particular for a variety of novel product formats.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

Bioss In Vivo Biosimilar Antibodies

Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are...

LSBio virology research products

LSBio offers antibodies, proteins, ELISA kits, assay kits and chemical compounds used by...

Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates

The products provide research flow cytometry labs with a low-noise solution, including single...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd